Related Experiment Video
Updated: May 22, 2026
07:30
A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact
Published on: September 21, 2017
The case for a vaccine injury compensation program for Canada
Kumanan Wilson1, Jennifer Keelan
1Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON. kwilson@ohri.ca
Summary
Canada lacks a national vaccine injury compensation program, a critical gap in public health policy. This article explores the rationale and optimal design for establishing such a program in Canada.
Area of Science:
- Public Health
- Health Policy
- Immunization
Background:
- Canada has debated a national vaccine injury compensation program since the 1980s.
- The absence of such a program represents a significant gap in Canadian immunization policy.
- Many developed nations have established similar compensation frameworks.
Purpose of the Study:
- To outline the arguments supporting the implementation of a national vaccine injury compensation program in Canada.
- To propose suitable design elements for a Canadian vaccine injury compensation program.
Main Methods:
- Policy analysis
- Comparative policy review
- Argument synthesis
Main Results:
- Identification of key arguments for establishing a compensation program.
- Exploration of essential design considerations tailored to the Canadian healthcare system.
Conclusions:
- A national vaccine injury compensation program is warranted in Canada.
- Careful consideration of program design is crucial for effective implementation and public trust in immunization programs.
More Related Videos
Related Concept Videos
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:00Cellular Injury I: Introduction
Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...